Login

Financial Snapshot

Revenue
TTM
$238.0K
Gross Margin
TTM
42.63%
Net Income
TTM
-$283.7K
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
10.53%
Total Assets
2026 Q1
Total Liabilities
Last 4 Quarters
N/A
Book Value
Last 4 Quarters
N/A
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
Last 4 Quarters
N/A

Stock Price

Loading...
Market Cap: $9.54 Million

About Quarta-Rad Inc

Quarta-Rad Inc (OTC: QURT) is a software development company transitioning from radiation detection equipment distribution to AI-powered call center software. Revenue is generated through development contracts and software licensing, primarily via its wholly owned subsidiary Sellavir, Inc. The company reported total revenues of $244,955 for the year ended December 31, 2025, comprised of $9,955 from the legacy Quarta-Rad radiation detection segment and $235,000 from Sellavir, compared to $106,797 in total revenues for the year ended December 31, 2024. The legacy radiation detection business is in active wind-down as of 2024. Sellavir is developing CenterEye, a call center software platform using AI and analytics, with a January 2026 integration partnership signed with Genesys Cloud Services, Inc. As of December 31, 2025, the company held $72,909 in cash and carried $289,529 in liabilities, with a going concern qualification disclosed in the 10-K filed March 31, 2026. The administrative office is a virtual office located at 1201 N. Orange St., Suite 700, Wilmington, DE 19801. Victor Shvetsky has served as Chief Executive Officer since the company's founding.

Revenue model
Software development contracts and licensing fees through Sellavir, Inc., with residual transactional product sales from the legacy radiation detection equipment segment being wound down. As of FY2025, Sellavir's sole disclosed revenue stream is from a Japanese reseller. The legacy Quarta-Rad segment generated $9,955 in net revenues for FY2025, down 85.10% from $66,797 in FY2024.
Products and services
CenterEye, a call center software platform built on AI and advanced analytics, developed by Sellavir, Inc. Planned integrations with Genesys Cloud, NICE CXone, and Avaya as of the 10-K filed March 31, 2026. Legacy Radex-series radiation detection equipment, now in wind-down.
Customers and end markets
Call center operators as the target end market for CenterEye software. As of the 10-K filed March 31, 2026, Sellavir's sole active revenue source is a Japanese reseller. Legacy customers included homebuilders, home renovation contractors, and third-party resellers of radiation detection equipment in North America.
Value-chain role
Software developer and distributor. Sellavir builds and licenses AI-driven call center software, integrating with third-party platforms such as Genesys Cloud. The legacy segment operated as a product reseller sourcing radiation detection equipment from related and third parties.
Geographic exposure
Administrative operations based in Wilmington, DE (virtual office). Legacy product sales were directed at North American markets. Sellavir's disclosed revenue as of the 10-K filed March 31, 2026 flows from a Japanese reseller.
Competitors
Genesys Cloud Services, NICE CXone, Avaya

Source: SEC 10-K, filed 2026-03-31

Industry: Industrial Instruments For Measurement, Display, and Control

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support